<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate whether the selective AT1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> <z:chebi fb="0" ids="5959">irbesartan</z:chebi> exerts neuroprotective effect on focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in normotensive rats </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: <z:hpo ids='HP_0002637'>Cerebral ischemia</z:hpo> was induced by middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) for 90 min followed by reperfusion, with the monitoring of laser Doppler flowmetry </plain></SENT>
<SENT sid="2" pm="."><plain>To avoid the interaction with peripheral AT1 receptors, <z:chebi fb="0" ids="5959">irbesartan</z:chebi> was infused intracerebroventricularly (ICV) at a dose which effectively inhibited brain- but not vascular AT1 receptors </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological status was evaluated daily after MCAO </plain></SENT>
<SENT sid="4" pm="."><plain>Rats were killed and brain samples were collected for the measurement of <z:mpath ids='MPATH_124'>infarct</z:mpath> size and immunohistochemical evaluation of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> by deoxynucleotidyltransferase-mediated biotinylated <z:chebi fb="6" ids="15713">UTP</z:chebi> nick end labeling (TUNEL) and expression of activated Caspase-3 and the cleavage fragment of poly (<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase (PARP) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Treatment with <z:chebi fb="0" ids="5959">irbesartan</z:chebi> improved significantly the neurobehavioral functions after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The <z:mpath ids='MPATH_124'>infarct</z:mpath> size was reduced about 42% on day 7 after MCAO (P &lt; 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>Meanwhile,<z:chebi fb="0" ids="5959">irbesartan</z:chebi> treatment significantly decreased the number of TUNEL-positive cells in the penumbra </plain></SENT>
<SENT sid="8" pm="."><plain>The expression of activated Caspase-3 and the downstream cleavage fragment of poly (<z:chebi fb="13" ids="16761">ADP</z:chebi>-<z:chebi fb="1" ids="33942">ribose</z:chebi>) polymerase in the penumbra were also inhibited by <z:chebi fb="0" ids="5959">irbesartan</z:chebi> therapy on day 3 after transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: Angiotensin AT1 receptor <z:chebi fb="68" ids="48706">antagonist</z:chebi> exhibits neuroprotection against transient <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> in the brain </plain></SENT>
<SENT sid="10" pm="."><plain>The neuroprotective effects in ischemic tissue may be associated with its inhibition of apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> in the penumbra </plain></SENT>
</text></document>